fluorouracil has been researched along with bardoxolone methyl in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ai, Y; Huang, Z; Kang, F; Lai, Y; Peng, S; Tian, J; Xue, X; Zhang, Y | 1 |
Alho, DPS; Figueiredo, SAC; Gonçalves, BMF; Leal, AS; Mendes, VIS; Salvador, JAR; Silvestre, SM; Valdeira, AS | 1 |
1 review(s) available for fluorouracil and bardoxolone methyl
Article | Year |
---|---|
Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
Topics: Animals; Antineoplastic Agents; Chemistry Techniques, Synthetic; Humans; Indolequinones; Neoplasms; Oleanolic Acid; Structure-Activity Relationship; Triterpenes | 2017 |
1 other study(ies) available for fluorouracil and bardoxolone methyl
Article | Year |
---|---|
Synthesis of CDDO-amino acid-nitric oxide donor trihybrids as potential antitumor agents against both drug-sensitive and drug-resistant colon cancer.
Topics: Amino Acids; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Molecular Structure; Nitric Oxide Donors; Oleanolic Acid; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |